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The lens is an avascular tissue, separated from the aqueous and vitreous humors by its own extracellular matrix, the lens
capsule. Here we demonstrate that the lens capsule is a source of essential survival factors for lens epithelial cells. Primary
and immortalized lens epithelial cells survive in low levels of serum and are resistant to staurosporine-induced apoptosis
when they remain in contact with the lens capsule. Physical contact with the capsule is required for maximal resistance
to stress. The lens capsule is also a source of soluble factors including fibroblast growth factor 2 (FGF-2) and perlecan, an
extracellular matrix component that enhances FGF-2 activity. Matrix metalloproteinase 2 (MMP-2) inhibition as well as
MMP-2 pretreatment of lens capsules greatly reduced the protective effect of the lens capsule, although this could be
largely reversed by the addition of either conditioned medium or recombinant FGF-2. These data suggest that FGF-2
release from the lens capsule by MMP-2 is essential to lens epithelial cell viability and survival.
INTRODUCTION
Cell survival requires the continued exposure to specific
survival factors. In a classic study (Ishizaki et al., 1993), lens
epithelial cells were shown to survive in culture, in the
absence of cell–cell contact, as long as the right growth
factor cues were available. These factors could be provided
exogenously either in the form of conditioned media or in
serum supplement (Ishizaki et al., 1993), leading to the
widely accepted general hypothesis that cells are pro-
grammed to die unless the appropriate signals are received.
The recent proposal of the extracellular matrix (ECM)
reservoir hypothesis suggests that the ECM itself can act as
a reservoir for growth and survival factors (Bergers et al.,
2000; Mott and Werb, 2004) that are released via the action of
various matrix metalloproteinases (MMPs; reviewed in Mc-
Cawley and Matrisian, 2001; Mott and Werb, 2004). MMPs
have been shown to release fibroblast growth factor (FGF)-2
(MMP-1, -3; Whitelock et al., 1996) and fibroblast growth
factor receptor (FGFR)-1 (MMP-2; Levi et al., 1996), activate
transforming growth factor (TGF)-1/2 (Yu and Stamenk-
ovic, 2000), and to both activate and release insulin-like
growth factor (IGF)-1 (MMP-1, -2, -3, and -9; Fowlkes et al.,
1994; and MMP-2, -3, and -7; Imai et al., 1997). MMPs are
therefore an essential component in this proposed role for
the ECM in cell survival and cell proliferation (Ishizuya-Oka
et al., 2000; Wiseman et al., 2003). From such data, we can see
that the ECM reservoir hypothesis requires three essential
components: an ECM, growth factors sequestered by the
ECM, and the presence of MMPs to release the growth
factors from the ECM. This hypothesis changes our percep-
tion of the ECM as it can no longer be considered to solely
provide a physical support or appropriate cues for integrin
signaling (Hynes, 1992; Adams and Watt, 1993), but is also a
source of cell proliferation and survival factors (Klagsbrun,
1990; Taipale and Keski-Oja, 1997; Bergers et al., 2000; Mott
and Werb, 2004; Tran et al., 2004).
This reservoir hypothesis was proposed on the basis of
studies on angiogenesis and tumor progression. For in-
stance, vascular endothelial growth factor (VEGF) release is
necessary for tumor progression by driving the activation of
quiescent cells in the vasculature (Bergers et al., 2000), and
MMPs were shown to increase the bioavailability of VEGFs
needed for this (Hashimoto et al., 2002). The ECM reservoir
hypothesis clearly has implications for a broad range of
other cell biological situations, including tumor metastasis
(Fidler, 2002) and the establishment of stem cell niches (Rob-
erts et al., 1988; Carter et al., 2004; Leone et al., 2005).
In the experimental systems used to propose the ECM
reservoir hypothesis, the specific origin and site of growth
factor sequestration or even which cells produce the MMPs
(Bergers et al., 2000; Wiseman et al., 2003) are hard to iden-
tify. In many cases it is activities derived from other cells
that release growth factors from the ECM (Bergers et al.,
2000; Mott and Werb, 2004). We decided, therefore, to ex-
amine the reservoir hypothesis of the ECM in a defined
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system, namely the eye lens epithelium and its associated
ECM, the lens capsule, because the lens can be isolated intact
and free from other contaminating cells and tissues.
In this study, we show that the lens capsule maintains lens
epithelial cell viability even in the presence of apoptogens.
We confirm that lens epithelial cells produce several MMPs
including MMP-2, which releases FGF-2 from the lens cap-
sule as proof of principle for the ECM-reservoir hypothesis
in this system. MMP-2 is the most important MMP for
epithelial cell viability in this system, and our data show that
this activity, in combination with FGF-2 release, are key
aspects to the survival of lens epithelial cells on the lens
capsule.
MATERIALS AND METHODS
Bovine Lens Capsule Processing
Whole bovine eyes were obtained from Northern Counties Meat Group
(Sunderland, United Kingdom). The lenses were dissected out of the eyes
within12 h after culling and left overnight in DMEM (Sigma-Aldrich, Poole,
United Kingdom) supplemented with 0.1% (vol/vol) fetal calf serum (Sigma-
Aldrich), 2 mM l-glutamine, 200 U/l penicillin, and 0.2 mg/l streptomycin in
a 37°C, 5% (vol/vol) CO2 incubator. The next morning, the lens capsules were
dissected by placing the anterior capsule face-down and by cross-cutting and
pinning down the posterior capsule onto Sylgard-covered (Dow Corning,
Barry, United Kingdom) wells of a 12-well plate, with the inside of the
capsular bag facing upward, after which the fiber mass was removed. When
these capsules were to be seeded with cells, the capsules were then
trypsinized for 1 h (trypsin-EDTA provided by Sigma-Aldrich), washed once
in phosphate-buffered saline (PBS), once in 70% (vol/vol) ethanol, and twice
in PBS, after which they were left in PBS overnight in an incubator maintained
at 37°C and 5% (vol/vol) CO2.
Cells and Cell Lines
The cell line H36CE2 was established from the central epithelium of a lens
from a 3-y-old postmortem donor who died in 1994. These cells were immor-
talized with SV40 Large-T antigen, expressed in adenovirus, as described
previously (Andley et al., 1994; Kleinjan et al., 2001). Karyotype characteriza-
tion was undertaken (Rooney and Czepulkowski, 1992) and was in broad
agreement with previously published data for a SV40 Large-T antigen im-
mortalized lens epithelial cell line, B3 (Andley et al., 1994). RT-PCR confirmed
that the H36CE2 cells retained a lens epithelial cell phenotype (A-crystallin,
B-crystallin, and FoxE3 positive). RNA was extracted from the cells using the
GenElute Mammalian Total RNA kit (Sigma-Aldrich), and cDNA was gen-
erated according to the manufacturer’s instructions (Superscript First strand
synthesis system, Invitrogen, Paisley, United Kingdom). Primary bovine lens
epithelial cells were removed from lens capsules by trypsinization, seeded
onto plastic dishes, and grown in DMEM supplemented with glutamine,
penicillin, streptomycin, and 10% (vol/vol) FBS.
Cell Viability Studies
Cells were seeded at a concentration of 50,000 cells/ml in 12-well plates with
or without a lens capsule covering the bottom of the well. Cells were cultured
in high serum (10% [vol/vol] fetal calf serum) or low serum (0.1% [vol/vol]
fetal calf serum) supplemented media. Viable cell number was determined at
various time points after seeding, by the one-step CellTiter 96 Aqueous
NonRadioactive Cell proliferation Assay kit (Promega, Southampton, United
Kingdom) following manufacturer’s instructions. Briefly, after a change of
media, 100 l of reagent was added to 500 l of media in the presence of the
cells and left for 90 min after which media samples were read on an ANTHOS
LUCY1 plate reader (Anthos Labtec Instruments, Leighton Buzzard, United
Kingdom) at 490 nm and absorbance values recorded. Staurosporine was
added 48 h after seeding to allow cells to adjust to their respective substrates.
MMP inhibitors were added at the time of seeding the cells to prevent all
MMP-ECM interactions from the start of the experiment. Staurosporine
(Tamaoki et al., 1986; Oncogene Research Products, Nottingham, United
Kingdom) was used at 0.5 M (protein kinase A [PKA] IC50  7 nM, PKC
IC50  0.7 nM, PKG IC50  8.5 nM), OA-Hy (Emonard et al., 1999; Calbio-
chem, Nottingham, United Kingdom) at 100 M (Ki  1.7 M) and MMP
inhibitor II (Pikul et al., 1998; Calbiochem) at 5 nM (MMP-1 IC50  24 nM,
MMP-3 IC50  18.4 nM, MMP-7 IC50  30 nm, and MMP-9 IC50  2.7 nM).
The concentration chosen for the MMP inhibitor II is selective for MMP-9 (see
IC50 values above), whereas the concentration chosen for the OA-Hy has been
shown to be selective for MMP-2 inhibition (Polette et al., 1999), which we
have confirmed independently by zymography (data not shown).
TUNEL Studies
Cells were cultured in high serum (10% [vol/vol] fetal calf serum) sup-
plemented media with or without 0.5 M staurosporine on either glass
coverslips or bovine lens capsules cleaned of all primary cells. After 48 h,
cell apoptosis was assessed by TUNEL staining (terminal dUTP nicked-
end labeling) and propidium iodide counterstaining (Boehringer-Mann-
heim, Lewes, United Kingdom) following the manufacturer’s protocol.
Apoptotic Morphology Quantification
Cells were cultured on either glass coverslips or bovine lens capsules cleaned
of all primary cells. Cell culture conditions were high serum (10% [vol/vol]
fetal calf serum) supplemented medium with or without 0.5 M staurospor-
ine. After 48-h exposure to staurosporine, cells were fixed in 4% wt/vol
paraformaldehyde and stained with DAPI (1 g/ml in PBS) in order to
visualize the nuclei. They were then mounted in Citifluor and examined with
fluorescence microscopy using a Zeiss Axioplan microscope (Welwyn Garden
City, United Kingdom). The capsules were mounted by being placed, cells-up,
onto a microscope slide. The coverslips or capsules were examined, and cells
were counted under 40 magnification until either a total of 1000 cells had
been counted or until 100 fields had been examined, whichever came first.
Each cell counted was scored as either normal or apoptotic (with compressed
and/or fragmented chromatin; i.e., a pyknotic nucleus). The number of apo-
ptotic nuclei was then expressed as a percentage of the total number of cells
counted. Three independents repeats were made for each data point, and the
significance of the results gathered was assayed by 2 test.
Coculture and Conditioned-Media Experiments
Isolated bovine lens capsules were cleaned of cells as described above. For the
coculture experiments, a capsule was placed in the bottom chamber of the
well in a 12-well plate as required. A semipermeable membrane insert (Fal-
con/Becton Dickinson, Plymouth, United Kingdom) was added to each well,
giving a top chamber, which contained a coverslip seeded with 12,500 cells.
This cell number was calculated to reflect the difference between the surface
area of the coculture insert compared with the area of the lower well to ensure
that the starting cell density remained constant for both chambers. For the
conditioned-media experiment, lens capsules were kept in low serum (0.1%
[vol/vol] fetal calf serum) supplemented media for 72 h. In some instances,
the lens capsules were pretreated with 80 ng of human recombinant MMP-2
in low serum media (R&D Systems, Abingdon, United Kingdom). These
conditioned media were sometimes added back to fresh lens capsules. Cell
viability was monitored by the one-step CellTiter 96 Aqueous NonRadioac-
tive Cell proliferation Assay kit (Promega) as described above.
Cell Cycle Analysis
H36CE2 cells were cultured in 10% (vol/vol) fetal calf serum-supplemented
cell culture medium on either uncoated plastic dishes or bovine lens capsules
that had been cleaned of all primary cells, at a seeding density of 50,000 cells
per well. After 48 h, the cells were processed for cell cycle analysis following
the CyStain DNA 2step (PARTEC, Münster, Germany) protocol. Briefly, cells
were detached with trypsin, spun down for 5 min at 1000 rpm, and then
resuspended in nuclear extraction buffer and left at room temperature for 20
min, after which cells were spun down for 10 min at 1000 rpm, fixed in cold
70% ethanol, and left at 20°C until batch analysis. Immediately before
analysis, cells were spun down and resuspended in nuclear extraction buffer
and then left at room temperature for 10 min, before addition of the staining
solution. Samples were run on a FACSAria flow cytometer (Becton Dickinson)
and analyzed using a 60 mW UV laser. Doublets were discriminated against
using Area versus Width of the 450-nm signal from DAPI. Data were ana-
lyzed by FlowJo software (Tree Star, Ashland, OR), and the G1, S, and G2
ratio was determined by the Watson (pragmatic) method provided within the
FlowJo software.
Real-Time Analysis Using TaqMan Low-Density Arrays
RNA was extracted from the cells using the GenElute Mammalian Total RNA
kit (Sigma-Aldrich) and cDNA generated according to the manufacturer’s
instructions (Superscript First-strand Synthesis System, Invitrogen). TaqMan
low-density array (LDA) enables quantitative real-time PCR in a 384-well
low-density array. Pre-designed TaqMan primers and probes sets for 48 target
genes were chosen from an on-line catalogue (http://www.appliedbiosystems.
com/) and manufactured by Applied Biosystems (Foster City, CA). Each array
contained eight sample ports, with each feeding 48 reaction wells. LDAs were
run according to the manufacturer’s protocol. Briefly, each sample port was
loaded with 100 l PCR mix (100 ng of total RNA converted to cDNA and 2
TaqMan Universal PCR mix; Applied Biosystems). Thermal cycling condi-
tions were as follows: 50°C, 2 min; 94.5°C, 10 min; 40 cycles of 97°C, 30 s; and
59.7°C for 1 min and were performed on the ABI Prism 7900HT sequence
detection system (Applied Biosystems, Warrington, United Kingdom). Ex-
pression levels of target genes were normalized to GAPDH. Data were
analyzed using 7900HT system and SDS software. The cycle threshold (Ct)
value reflects the cycle number at which the fluorescence generated within a
reaction crosses the threshold. Gene expression values were calculated based
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on the Ct method where Ct represents the Ct of the target minus that of
GAPDH. Due to the exponential nature of PCR, Ct was converted to linear
form using the equation: 2(Ct), to give the relative quantity of the target
gene expression. The amplification efficiencies associated with TaqMan gene
expression assays designed by ABI are equal and thus allow expression levels
of target genes to be compared with values obtained for cells grown on plastic
being used as the baseline.
Immunoblotting
Immunoblotting was used to confirm the presence of gelatinases in condi-
tioned medium from H36CE2 cells grown on plastic and on the lens capsule.
Conditioned media samples were collected after 96-h culture and concen-
trated 25-fold using an Amicon Ultra-4 centrifuge filter with a 30K nominal
molecular weight limit (Millipore, Molsheim, France) as described elsewhere
(Fuchshofer et al., 2003). For MMP-2 detection the culture medium used was
serum-free to prevent bovine serum albumin (BSA) obscuring the MMP-2
signal. For MMP-9 detection, the culture medium used was supplemented
with 0.1% (vol/vol) serum in accordance with the rest of our experiments.
Samples were separated for 1 h at 200 V on a 12% (wt/vol) acrylamide gel and
blotted onto a nitrocellulose membrane (Whatman, Dassel, Germany) for 2 h.
The membrane was washed in blocking buffer (5% [wt/vol] milk in TTBS) for
1 h at room temperature, after which the membrane was incubated in the
primary antibody solution overnight at 4°C, rinsed twice, and incubated with
the secondary antibody solution for 1 h at 37°C. After further rinsing, the
membrane was incubated for 5 min in the dark in enhanced chemilumines-
cence (ECL) solution, and the image was collected using a cooled CCD camera
system (Fujifilm Intelligent Dark Box II, Tokyo, Japan). Images were pro-
cessed using the companion computer program LAS-1000 and Adobe Photo-
shop CS (San Jose, CA). Mouse monoclonal antibodies to MMP-2 and MMP-9
(clone 101724 and 4H3, respectively; R&D Systems) were used that detect
both latent and active forms of these MMPs. Human recombinant latent
MMP-2 and MMP-9 (R&D Systems) were used as positive controls.
Immunofluorescence Confocal Microscopy and Scanning
Electron Microscopy
Bovine lens capsules that had been cleaned of all primary cells as described
above were treated with 80 ng of recombinant human MMP-2 (R&D Systems)
per capsule for 72 h in substrate buffer (5 mM CaCl2, 50 mM Tris, pH 8.0). For
immunofluorescence microscopy analysis, 10-m frozen sections were made
using a Leica CM3050S cryostat (Milton Keynes, United Kingdom), and
sections were fixed in 4% paraformaldehyde for 10 min, permeabilized in 1%
NP40 in PBS for 15 min, and blocked in 10% goat serum in PBS for 20 min.
Primary polyclonal anti-FGF-2 (clone PC16, Calbiochem) and monoclonal
anti-perlecan (clone A7L6, Chemicon) antibodies were used. Secondary anti-
bodies used were TRICT anti-rabbit IgG (Sigma-Aldrich) and fluorescein
isothiocyanate (FITC) anti-mouse IgG (Scottish Antibody Production Unit,
Carluke, Scotland). Pictures were taken using a Bio-Rad Microradiance con-
focal microscope coupled to Lasersharp 2000 software (Bio-Rad Laboratories,
Ltd., Hemel Hampstead, United Kingdom). For scanning electron microscopy
analysis, whole lens capsules were fixed in 2% gluteraldehyde in PBS over-
night, washed two times for 10 min in 0.2 M sodium cacodylate, pH 7.4,
incubated in 1% osmium tetroxide in 0.2 M sodium cacodylate, pH 7.4 for 1 h,
washed 10 min in water, dehydrated through ethanol series (50, 75, 90, 95,
100, and 100%, 5 min each), critical point-dried with CO2, and coated with 5
nm platinum in a Cressington 308 coater. They were then viewed in a Hitachi
S-5200 feSEM at 10 kV accelerating voltage.
ELISA Measurement of Growth Factor Levels
FGF-2 ELISA (R&D Systems) was conducted according to manufacturer’s
instructions. The assay measured both free and bound FGF-2 forms. Samples
consisted either of unconcentrated medium taken from BLEC and H36CE2
cells grown on lens capsules in 0.1% (vol/vol) serum for 48 h or of uncon-
centrated substrate buffer (5 mM CaCl2, 50 mM Tris, pH 8.0) taken from lens
capsules that had been cleaned of all cells and exposed to human recombinant
MMP-2 for 72 h.
Data Analysis
The absorbance values recorded using the one-step CellTiter 96 aqueous
nonradioactive cell proliferation assay kit (Promega) and the ELISA kit (R&D
Systems) were converted into viable cells number and growth factor level,
respectively, using standard curves for each cell line and growth factor,
respectively. Six wells were used for each treatment per experiment. The data
from three independent experiments were pooled, and the mean and SE of the
mean calculated for each treatment. Significance between treatments was
determined by an independent-sample, two-tailed t test, and pairwise com-
parisons were made, with a significance level set at 0.05.
RESULTS
The Lens Capsule Protects Lens Epithelial Cells against
Serum Deprivation and Staurosporine-induced Apoptosis
Previous experiments conducted with human lens explants
have shown that lens epithelial cells kept within the capsular
bag can proliferate in the total absence of serum (Wormstone
et al., 1997), whereas lens epithelial cells grown on a plastic
substrate undergo apoptosis when deprived of serum
(Wang et al., 1999). In low levels of serum (0.1% [vol/vol]
serum), primary bovine lens epithelial cells, BLEC, and im-
mortalized human lens epithelial cells, H36CE2, attached
with equal efficiency to both plastic dishes and bovine lens
capsules, as shown by the measurement of cell number 1 h
after plating (Figure 1A). After 96-h exposure to 0.1% (vol/
vol) serum, however, no BLEC and H36CE2 cells survived
when plated onto plastic dishes (Figure 1B, pl-0.1% FCS). In
contrast, cells plated onto bovine lens capsules were readily
detected (Figure 1B, cap-0.1% FCS).
These data suggested that the lens capsule protected the
lens epithelial cells against cell death in low levels of serum.
To test this hypothesis, we examined the ability of the bo-
vine lens capsule to protect lens epithelial cells against stau-
rosporine-induced apoptosis in the presence of 10% (vol/
vol) serum. In this experiment, the ability of staurosporine to
kill cells grown on the plastic culture dishes (Figure 2, A and
B, pl-c, pl-s) was compared with those cells grown on lens
capsules (Figure 2, A and B, cap-c, cap-s). On plastic, there
was a dramatic decrease in cell number in both cell lines
after 48 h of staurosporine treatment (Figure 2, A and B, pl-c
and pl-s). When cells were grown on the lens capsule sub-
strate, however, significantly less cell loss was observed
(Figure 2, A and B, cap-c and cap-s). In fact the BLEC cells
even appeared to be insensitive to staurosporine treatment
(Figure 2A, cap-c and cap-s), perhaps reflecting the primary
origin of these cells compared with the large T antigen–
immortalized H36CE2 cells. In agreement with these cell
viability results, when BLEC cells were TUNEL stained,
those treated for 48 h with staurosporine in 10% (vol/vol)
medium resulted in the detection of apoptotic DNA damage
for cells grown on glass coverslips (Figure 2, C and D), but
not for cells grown on the lens capsule (Figure 2, E and F).
Quantification of apoptotic damage, by counting the per-
Figure 1. Lens epithelial cells are protected against
serum deprivation when cultured on the lens capsule.
BLEC and H36CE2 cells were seeded onto either plastic
dishes (pl) or lens capsules (cap) in 0.1% (vol/vol) fetal
cal serum (FCS). After 1 h in culture (A), there was no
statistical difference (p  0.05 for both BLEC and
H36CE2) between the numbers of cells attached to the
lens capsule or to the plastic dishes (bars show the
average number of cells attached to the lens capsules as
a percentage of the average number of cells attached to
the plastic dishes). After 96 h in culture (B), viable cells
were only detected on the lens capsules (cap). Those on plastic (pl) appeared not to have survived.
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centage of pyknotic nuclei in BLEC cells grown in high
serum (10% [vol/vol]) medium in the presence of stauro-
sporine for 48 h, showed a significantly greater number of
apoptotic nuclei in cells cultured on coverslips, rather than
on lens capsules (Figure 2G). These results strongly suggest
that the lens capsule is capable of preventing staurosporine-
induced apoptosis in lens epithelial cells.
To test whether the lens capsule had a solely antiapoptotic
effect, rather than a mixture of proproliferative and anti-
apoptotic activities, we subjected H36CE2 cells grown on
either uncoated plastic dishes or bovine lens capsules to cell
cycle analysis. After 48 h culture in 10% (vol/vol) serum-
supplemented cell culture medium, only a small, nonsignif-
icant increase in the G2 population was observed in H36CE2
cells grown on the lens capsules, compared with H36CE2
cells grown on plastic (Table 1), suggesting that the presence
Figure 2. Lens epithelial cells are protected against staurospo-
rine-induced apoptosis when cultured on the lens capsule. (A
and B) BLEC cells (A) and H36CE2 cells (B) were grown on either
uncoated plastic dishes (pl-c) or on bovine lens capsules (cap-c)
in 10% (vol/vol) serum and then challenged with 0.5 M
staurosporine (pl-s; cap-s). After 48-h exposure to staurosporine,
most of the BLEC (A, pl-s) and H36CE2 (B, pl-s) grown on the
plastic dishes did not survive compared with controls (A, B; pl-c
and pl-s; p  0.05 for both BLEC and H36CE2). When grown on the
lens capsules (A and B, cap-s), there was, however, a smaller de-
crease in cell number (A and B; cf. cap-c and cap-s; p 0.05 and p
0.05 for BLEC and H36CE2, respectively). (C–F) Immunofluores-
cence microscopy of BLEC cells labeled with both propidium iodide
(red) and TUNEL staining (green) and grown on either glass cov-
erslips (C and D) or on bovine lens capsules (E and F) in the absence
(C and E) or presence (D and F) of 0.5 M staurosporine in media
containing 10% (vol/vol) serum. After 48 h in the presence of
staurosporine, chromatin reorganization was frequently observed in
the nuclei of cells grown on glass as detected by propidium iodide
staining. These propidium iodide–positive nuclei were also largely
TUNEL-positive, indicating that significant DNA damage has also
occurred, as indicated by the yellow color of their nuclei (arrows). In
contrast, cells grown on the bovine lens capsule were mostly not
TUNEL positive and chromatin reorganization was also not usually
seen (F). Scale bars, 10 m. (G) BLEC cells grown on either glass
coverslips (gl) or on bovine lens capsules (cap) in the absence (-c) or
presence (-s) of 0.5 M staurosporine in media containing 10%
(vol/vol) serum were labeled with DAPI and then scored for the
presence of apoptotic nuclei. The number of apoptotic cells after
48-h exposure to staurosporine was then expressed as percentage of
total cell number as described in Materials and Methods. In the
absence of staurosporine, the percentage of apoptotic cells was low
for cells grown on both glass (gl-c) and lens capsule substrates
(cap-c). With the addition of staurosporine, cells grown on the
coverslips exhibited a very large increase in the number of apoptotic
cells (gl-p and gl-s; p  0.05). In contrast, cells grown on the lens
capsule exhibited a much smaller increase in number of apoptotic
cells (cap-s).
Table 1. Cell cycle analysis of H36CE2 cells
Cell
treatment % G1 population % S population % G2 population
H36CE2 pl 44.6 6.5 38.6 4.9 11.6 2.4
H36CE2 cap 44.9 8.1 34.0 7.9 17.1 3.9
H36CE2 cells were grown either on uncoated plastic dishes (pl) or
on bovine lens capsules (cap) in 10% (vol/vol) serum supplemented
medium for 48 h before being collected and processed for cell cycle
analysis. The percentages of cells within the G1 and S populations
were similar for both substrates, with a small, nonsignificant (2 test;
p  0.10) increase in the G2 population when H36CE2 cells were
grown on bovine lens capsules. Numbers shown are the average 
SD of three independent repeats.
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of the lens capsule per se does not strongly affect the cell
cycle of lens epithelial cells.
MMPs Are Expressed by Lens Cells
Others have reported that lens epithelial cells grown on the
lens capsule produce matrix metalloproteinases, and specif-
ically MMP-2 and -9, when exposed to stress (Tamiya et al.,
2000). To investigate whether this expression pattern would
be conserved in our system, RNA was isolated from the
human H36CE2 cells grown for 48 h in 0.1% (vol/vol) serum
on bovine lens capsules and uncoated plastic dishes, and the
expression profile for ADAMTS-1 to -20, MMP-1 to -28 and
TIMP-1 to -4 were monitored by a TaqMan gene expression
assays (representative result shown in Supplementary Fig-
ure 1). GAPDH was used to normalize the expression levels
for the two values, and then the relative change in RNA
levels for the cells grown on the lens capsule versus the
plastic were plotted on a log scale (Figure 3A). These data
confirmed the presence of MMP-2 and also identified
MMP-1, -3, -14, and -15 as expressed by H36CE2 cells grown
on both substrates. Only ADAMTS-4 and MMP-2, however,
were consistently up-regulated in cells grown on the lens
capsules compared with cells grown on plastic, and MMP-9
was not detected for cells grown on either substrate (Figure
3A). The expression of the inhibitors TIMP-1 and -4 (Brew et
al., 2000) were also consistently down-regulated in cells
grown on lens capsules compared with those grown on
plastic (Figure 3A). The presence and activation status of
MMP-2 was checked by immunoblotting of lens cell condi-
tioned media after 48 h of culture in serum- free medium
(Figure 3B). The pro-MMP-2 form (72 kDa) and to a lesser
extent its active cleaved (57 kDa) form were present in the
media from H36CE2 cells grown on plastic dishes. Condi-
tioned media from cells grown on the capsule contained
predominantly the cleaved 57-kDa active form of MMP2.
Again, MMP-9 was not detected (Figure 3C) confirming the
RNA expression data. Collectively, these data show that
culture of lens epithelial cells on the lens capsule correlates
with higher levels of MMP-2 expression and activation.
Soluble Survival Factors Are Released from the Lens
Capsule
The presence of active MMP-2 suggested that ECM degra-
dation products could be released from the lens capsule to
enable the survival of the lens epithelial cells. To address
this question, we cultured H36CE2 with lens capsules using
a coculture chamber system containing 0.1% (vol/vol) se-
rum supplemented media. Here, the H36CE2 cells were
grown in an upper chamber, separated by a semipermeable
membrane from a lower chamber. Various additions were
made to the lower chamber, such as H36CE2 cells only
(Figure 4; Coculture; with cells in bottom chamber; no cap),
a lens capsule alone (Figure 4; Coculture; no cells in bottom
chamber; plus cap) or H36CE2 cells grown on a lens capsule
(Figure 4; Coculture; with cells in bottom chamber; plus
cap). After 48 h in culture, comparing the treatment cell
viability values to those for the controls (Figure 4; Controls;
pl, cap) showed H36CE2 cell number to be highest when
both lens capsule and cells were present in the bottom
chamber (Figure 4; Coculture; with cells in bottom chamber;
plus cap). These data suggest that soluble factors can be
released by attached cells from the lens capsule to maintain
the viability of H36CE2 cells in the upper chamber in low
serum conditions. This improved survival was, however,
still significantly less than that of H36CE2 cells grown in
direct contact with the lens capsule (Figure 4; Controls; cap).
Therefore, maximal lens cell viability in low-serum condi-
tions requires both physical attachment to the lens capsule
as well as the release of soluble factors from the matrix.
Figure 3. MMP-2 expression and activation are increased in
H36CE2 cells grown on the lens capsule compared with H36CE2
cells grown on plastic. (A) Analysis of the TaqMan gene expression
array data plotted as relative change (Ct) in transcript levels
between extracts from an equal number of cells cultured for 48 h on
the lens capsule (bars) and the plastic substrate (baseline). These
data show that H36CE2 cells grown on the lens capsule consistently
express more ADAMTS-4 and MMP-2 and less TIMP-1 and - 4 than
H36CE2 grown on plastic. MMP-9 mRNA expression was not de-
tected. (B and C) Conditioned medium from H36CE2 cells grown on
the plastic (pl) and the lens capsule (cap) for 48 h were concentrated
by centrifugation and analyzed by immunoblotting for the presence
of MMP-2 (B) and MMP-9 (C). Human recombinant latent gelati-
nases (hrMMP-2 and -9; asterisks) were included as standards.
MMP-2 was detected in the medium from cells grown on both
substrates in serum-free medium. Serum-free medium was used to
prevent BSA from obscuring the MMP-2 protein signal after sample
concentration. In medium from the lens capsule cultures, MMP-2
was predominantly detected as the cleaved active form (upper
arrowhead; B) with a further cleaved minor form (lower arrow-
head), whereas in medium from plastic cultures MMP-2 was mainly
detected in the latent form (asterisk). MMP-9 was not detected in
medium from cells grown on either substrate in 0.1% (vol/vol)
serum conditions.
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FGF-2 Is Released from the Lens Capsule by MMP-2
To test whether MMP-2 could release growth factors from
lens capsules, human recombinant MMP-2 (R&D Systems,
Minneapolis, MN) was added to bovine lens capsules which
had been cleaned of cells beforehand and the presence of
growth factor in MMP-2-treated capsules (Figure 5, A–D)
was investigated. FGF-2 (McAvoy and Chamberlain, 1989;
Le and Musil, 2001), IGF-1 (Piatigorsky et al., 1973; Shirke et
al., 2001), and TGF-2 (Luetteke et al., 1993; Weng et al., 1997)
have all been demonstrated as important for lens cell growth
and differentiation. As visualized by immunofluorescence
microscopy (Figure 5, A–D), even after 72 h of exposure in
substrate buffer, FGF-2 and its binding partner perlecan
(Roghani et al., 1994; Venkataraman et al., 1994; Padera et al.,
1999) were concentrated at both inner and outer faces of the
anterior lens capsule (Figure 5, A and B) and could be
released with MMP-2 treatment (Figure 5, C and D). Levels
of released FGF-2 were significantly increased in the pres-
ence of human recombinant MMP-2, as detected by ELISA
(Figure 5E). In contrast, no significant IGF-1 or TGF-2
release by MMP-2 were detected by ELISA measurements of
conditioned buffer (data not shown). Also after 72-h expo-
sure, scanning electron microscopy of the inner surface of
the anterior lens capsule showed that the main morpholog-
ical features of the lens capsule were retained after MMP-2
treatment, although the finer filamentous organization was
lost (Figure 6, A and B). These data suggest that the lens
capsule contains a reservoir of FGF-2 at the cell-ECM inter-
face that can be released as a result of MMP-2 activity.
Subsequently, MMP inhibitors, and specifically MMP-2 in-
hibitors, should reduce the levels of FGF-2 released from the
capsule by lens cells. A selective MMP-2 inhibitor was used
to test this hypothesis. Inhibition of MMP-2 reduced the
levels of FGF-2 released into the medium for BLEC and
H36CE2 cells grown on lens capsules in 0.1% (vol/vol)
Figure 4. Both attachment and soluble factors are involved in
H36CE2 cells viability on the lens capsule. Controls, the maximum
cell viability potential of H36CE2 cells grown directly on both
plastic (pl) and the lens capsule (cap) was measured after 48 h in
0.1% (vol/vol) serum conditions. Coculture experiments, the effect
of the lens capsule upon H36CE2 cell viability was measured in a
coculture system in 0.1% (vol/vol) serum. In this coculture system,
H36CE2 viability was measured for cells grown on an insert con-
tained within a plastic dish well. This allowed for different combi-
nations of lens capsule and H36CE2 cells to be added to the bottom
chamber and for the effect of soluble factors upon the viability of the
H36CE2 cells grown on the well insert to be determined. After 48 h
in culture, in the absence of both cells and lens capsule in the bottom
chamber, H36CE2 viability was very similar to that seen for the
plastic control (cf. Coculture; ‘no cells in bottom chamber; no cap’
with Controls; pl; p  0.05). Adding a lens capsule to the bottom
chamber in the absence of any additional cells in this compartment
was also unable to increase significantly the base level of cell via-
bility for H36CE2 cells in the upper chamber (cf. Coculture, “no cells
in bottom chamber, plus cap” with Controls, pl; p  0.05). In
contrast, adding both a lens capsule and H36CE2 cells to the bottom
chamber significantly increased H36CE2 cell viability in the upper
chamber (cf. Coculture, “with cells in bottom chamber; plus cap”
with Controls; pl; p  0.05). The addition of H36CE2 cells alone to
the bottom chamber had no significant effect upon the viability of
H36CE2 cells in the upper chamber (cf. Coculture, “with cells in
bottom chamber; no cap” with Controls, pl; p  0.05).
Figure 5. MMP-2 can release lens capsule-bound FGF-2 and per-
lecan and affect the amount of FGF-2 accessible to cells grown on the
lens capsule. MMP-2 treatment of the lens capsule depletes capsule-
bound perlecan and FGF-2 stores. (A–D) Bovine lens capsules
cleaned of all primary cells were exposed to human recombinant
MMP-2 for 72 h in substrate buffer (5 mM CaCl2, 50 mM Tris-HCl,
pH 8.0) and then processed for immunofluorescence microscopy. In
the untreated lens capsules, perlecan (green; A) and FGF-2 (red; B)
were still concentrated at the outer and inner faces of the anterior
lens capsule. In MMP-2–treated lens capsules, both layers were
largely depleted [perlecan (green; C) and FGF-2 (red; D)]. Scale bars,
20 m. (E) Bovine lens capsules cleaned of all primary cells were
exposed to human recombinant MMP-2 for 72 h in substrate buffer
(5 mM CaCl2, 50 mM Tris, pH 8.0), and levels of FGF-2 released into
the medium were measured by ELISA. In the treated samples, levels
of FGF-2 released into the medium were significantly increased with
the addition of human recombinant MMP-2 (p  0.05). (F) FGF-2
release from the lens capsule by H36CE2 and BLEC cells is reduced
by MMP-2 inhibition. H36CE2 cells and BLEC cells were seeded
onto lens capsules in 0.1% (vol/vol) FCS-supplemented medium
and challenged with 100 mM OA-Hy as a selective inhibitor of
MMP-2. After 48 h, MMP-2 (cap-c: cap-2inh) inhibition resulted in
significant decreases in FGF-2 levels released into the medium as
measured by ELISA (p  0.05 for both BLEC and H36CE2).
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serum for 48 h (Figure 5F; cap-c and cap-2inh). Taken to-
gether, these data show that there are significant levels of
FGF-2 sequestered in the lens capsule, which can be released
by MMP-2.
MMP-2 Inhibition Decreases Lens Epithelial Cells
Viability
The effect of selectively inhibiting MMP-2 upon epithelial
cell viability was determined (Figure 7). After 48 h in 0.1%
(vol/vol) serum conditions, MMP-2 inhibition (Figure 7, A
and B, cap-2inh) significantly reduced the viability of both
H36CE2 cells and BLEC cells. MMP-2 inhibition, however,
did not prevent the initial attachment of H36CE2 cells to the
lens capsule (data not shown). To test whether the lens
capsule store of growth factors could be fully depleted by
MMP-2, we pretreated lens capsules with human recombi-
nant MMP-2 in 0.1% (vol/vol) serum for 72 h before cell
seeding (Figure 7, A and B, cap-2pre). This treatment very
effectively inhibited the viability of both primary bovine lens
epithelial cells (Figure 7A) and H36CE2 cells (Figure 7B).
Again, initial attachment of H36CE2 cells to MMP-2 pre-
treated lens capsules was not severely affected (data not
shown). The conditioned medium collected from the MMP-
2–treated capsules could partially prevent cell loss due to
MMP-2 inhibition (Figure 7, A and B, cap-2inhCM).
MMP-9 inhibition was also tested and was shown to have no
effect on either H36CE2 or BLEC cell viability after 48 h in
0.1% (vol/vol) serum conditions (Figure 7C). Taken to-
gether, these results suggest that MMP-2 is the most impor-
tant MMP for sustaining lens cell viability and that its effects
are mediated by soluble factors (e.g., FGF-2) released from
the lens capsule.
Readdition of FGF-2 Counteracts the Inhibition of
Epithelial Cell Proliferation by MMP-2
These data suggest that it should be possible to reverse the
effects of MMP-2 inhibition by simply providing media sup-
plemented with FGF-2, if this growth factor were key to lens
epithelial cell survival (McAvoy and Chamberlain, 1989;
Richardson et al., 1993; Le and Musil, 2001; Lovicu and
McAvoy, 2001). Supplementing the growth media of pri-
mary bovine lens epithelial cells with exogenous recombi-
nant FGF-2 in the presence of the selective MMP-2 inhibitor
OA-Hy, restored	70% of the proliferation level after 48 h in
0.1% (vol/vol) serum conditions (Figure 7D). These data
confirm that MMP-2 and FGF-2 are key components in
promoting lens epithelial cell stress resistance on the lens
capsule.
DISCUSSION
The Lens Capsule Generates a Microenvironment
Conducive to Epithelial Cell Stress Resistance
In this study, we describe the role for the lens capsule as an
ECM store of FGF-2, a growth factor required for lens epithelial
cell proliferation, migration and differentiation (Robinson,
2006), most likely via MAPK signaling (Lovicu and McAvoy,
2001; Iyengar et al., 2007). The data presented here provide
evidence of the protective role of this ECM store of FGF-2 in a
simple, well-defined experimental system that mimics the mi-
croenvironment of the lens after surgery or injury (Wormstone
et al., 1997; Tamiya et al., 2000). We have identified MMP-2 as a
major activity required to support lens cell viability, via the
release of FGF-2 from the lens capsule.
It has long been recognized that the ECM determines cell
proliferation and survival via integrin attachment and activa-
tion (Matter and Ruoslahti, 2001; Hynes, 2002). Indeed the
cross-talk between integrin signaling and growth factor recep-
tors (Schwartz and Ginsberg, 2002) is a clear indication of the
importance of both pathways to cell proliferation, survival, and
differentiation. The three-dimensional features of the ECM and
its stiffness provide additional cues to the microenvironment
that influences cell proliferation (Lo et al., 2000; Bissell et al.,
2002; Zahir and Weaver, 2004). Our data show that maximal
cell number is achieved only when the cells are in direct contact
with the lens capsule (Figure 4). These are essential features of
the ECM role in cell proliferation and differentiation, but
growth/survival factors also play an equally important role as
previously shown using the lens epithelial cell paradigm (Ish-
izaki et al., 1993). Our data extend these seminal studies by
identifying the lens capsule as a major source of the growth/
Figure 6. MMP-2 treatment affects the surface architecture of the
lens capsule. Bovine lens capsules cleaned of all primary cells were
exposed to human recombinant MMP-2 for 72 h in substrate buffer
(5 mM CaCl2, 50 mM Tris, pH 8.0) and prepared for SEM analysis as
described in Materials and Methods. (A) In the untreated lens cap-
sules, at low magnification the inner surface of the anterior capsule
had a homogenous appearance with an intricate meshwork of sur-
face material. At higher magnification (A, insert), this meshwork of
fine filaments was seen to be locally arranged in a honeycomb
pattern (A, inset, arrows). (B) In MMP-2–treated lens capsules, at
low magnification the ECM surface had a similar general appear-
ance but had lost the fine detail. The honeycomb surface structures
were removed and condensed remnants appeared in their place (B,
inset, arrows). Scale bars, 1 m; Scale bars, (insets) 0.2 m.
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survival factors and demonstrating the additional cues that are
required for lens epithelial cell stress resistance and viability
are provided by the lens capsule.
We have proposed a model (Figure 8) to link the physical
attachment to the lens capsule, MMP activity, and the sub-
sequent release of growth factors such as FGF-2 from the
lens capsule. In other systems, FGF-2 is able to induce gela-
tinase expression (Kohn et al., 1995; El Ramy et al., 2005;
Wang et al., 2005), suggestive of a positive feedback loop
between growth factor release and the expression/activation
of MMPs to support lens epithelial cell survival and main-
tain proliferation. Our data have also demonstrated how
important the physical contact with the lens capsule is to
enhance the effects of the released growth factors (Figure 4).
Figure 7. MMP-2 mediates lens epithelial cell viability via the
release of soluble factors from the lens capsule. (A and B) BLEC (A)
and H36CE2 (B) cells were grown in 0.1% (vol/vol) serum on lens
capsules that had been exposed previously to human recombinant
MMP-2 for 72 h (cap-2pre). After 48 h in culture, this pretreatment
caused a significant decrease in cell viability (A and B: cap-c and
cap-pre; p  0.05 for both BLEC and H36CE2). This decrease was
not significantly different from the decrease in cell viability obtained
when either BLEC or H36CE2 cells were exposed to the MMP-2
selective inhibitor OA-Hy for the 48-h culture time (A and B: cap-c
and cap-2inh; p  0.05 for both BLEC and H36CE2 and A and B:
cap-2pre and cap-2inh; p  0.05 for both BLEC and H36CE2). The
addition of conditioned medium from MMP-2 pretreated lens cap-
sules (CM) to either BLEC or H36CE2 cells grown on lens capsules
in the presence of MMP-2 selective inhibitor OA-Hy (A and B:
cap-2inhCM) partially reversed the decrease in lens epithelial cell
viability induced by the addition of selective MMP-2 inhibitor (A
and B: cap-2inh and cap-2inhCM; p  0.05 for both BLEC and
H36CE2, and A and B: cap-c and cap-2inhCM; p  0.05 and p 
0.05 for BLEC and H36CE2, respectively). (C) Exposure to MMP
inhibitor II as a selective MMP-9 inhibitor failed to decrease the cell
viability of either BLEC or H36CE2 cells grown on lens capsules in
0.1% (vol/vol) serum (cap-c and cap-9inh; p  0.05 for both BLEC
and H36CE2). (D) BLEC grown on the lens capsules were exposed
to 100 M MMP2-selective inhibitor OA-Hy (cap-2inh) in 0.1%
(vol/vol) serum-supplemented medium. The subsequent decrease
in cell viability (cap-c and cap-2inh) could be significantly, but not
completely, reversed by the single addition of recombinant FGF-2
(200 pg/ml; cap-2inh and cap-2inhFGF, p  0.05, and cap-c and
cap-2inhFGF, p  0.05).
Figure 8. The MMP-ECM-Growth factor (MEG) cycle for cell via-
bility. The presence and activity of MMP-2 in the lens cells’ envi-
ronment, likely after integrin-mediated gene transcription as de-
scribed for other systems (Troussard et al., 1999; Lee et al., 2005),
leads to the degradation of HSPGs in the ECM, allowing soluble
FGF-2 release into the media. FGF-2 then binds its receptor and
activates downstream signaling pathways (Lovicu and McAvoy,
2001; Chandrasekher and Sailaja, 2003; Iyengar et al., 2007) to pro-
mote cell survival. This represents the simplest form of the cycle and
does not exclude contributions from other proteinases, cryptogenic
ECM sites, and IGF-1 and TGF-2 release that can all influence
epithelial cell survival. In other systems, FGF-2 can feedback to
increase gelatinase expression (El Ramy et al., 2005; Wang et al.,
2005).
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In other systems, recent studies have suggested that MMP-2
gene expression could be induced via AP-1 after ILK acti-
vation after integrin engagement (Troussard et al., 1999; Lee
et al., 2005). It is the combination of these physical cues, the
availability of growth factors from the ECM and the produc-
tion of MMPs that support lens cell proliferation. We pro-
pose therefore the MEG cycle (MMP-ECM-Growth factor) to
account for our observations.
Lens epithelial cell stress resistance requires MMP-2
Others have reported the presence of MMP-2 in lens cells
grown on the lens capsule (Wormstone et al., 2002), with
the induction of both MMP-2 and -9 being conditional on
the addition of exogenous growth factors (Wormstone et
al., 2002) or oxidative stress (Tamiya et al., 2000). Both
MMPs are implicated in the TGF-–induced epithelial-
mesenchyme transition (EMT) of lens epithelial cells
(Dwivedi et al., 2006). In our model, we have demon-
strated that the presence of MMP-2, but not MMP-9, is
essential for lens epithelial cell resistance to serum depri-
vation on the lens capsule. The MMP-2 selective inhibitor
OA-Hy significantly inhibited epithelial cell viability,
whereas a selective MMP-9 inhibitor had no effect (Figure
7). Also, pretreatment of bovine lens capsules with human
recombinant MMP-2 for 72 h was sufficient to reduce cell
viability very effectively (Figure 7). Neither MMP-2 inhi-
bition nor MMP-2 pretreatment prevented cell attachment
to the lens capsule, although cell loss was detected as
early as 6 h after the start of both treatments (Figure 7).
This suggests that attachment to the substrate per se is not
sufficient to guarantee the long-term survival of lens cells
on their ECM. MMP-2 processing of the lens capsule and
the subsequent release of soluble factors is also needed.
MMP-2 inhibition significantly reduced the levels of
FGF-2 in conditioned media (Figure 7), but the decrease in
primary lens cell number was largely reversed by adding
recombinant FGF-2 (Figure 7). These data demonstrate the
importance of FGF-2 to lens cell survival, but they also
suggest that MMP-2 has other targets and activities in this
system because FGF-2 readdition did not completely re-
verse OA-Hy inhibition. At this stage, we cannot exclude
contributions from other MMPs expressed by lens cells
(Figure 3 and Supplementary Data). Also, the capsule
could contain low levels of other, as yet uncharacterized,
proteinases with the potential to release these growth
factors, which in combination would influence lens cell
survival, proliferation, and differentiation (Liu et al.,
1996). The bio-context of FGF-2 availability could also
influence its effect, because heparan sulfate proteoglycans
(HSPGs) that facilitate FGF-2 binding to its receptor
(Roghani et al., 1994; Venkataraman et al., 1994; Padera et
al., 1999) are also potential substrates for MMP-2 (Fowlkes
and Winkler, 2002). HSPs are important components of
the lens capsule (Azuma and Hara, 1998) and altering
their biosynthesis can cause both lens hypoplasia and
anophthalmia (Pan et al., 2006). Indeed, MMP-2 is also
known to activate latent cytokines, such as IL1-B and
TNF- (Fowlkes and Winkler, 2002) and most recently
been shown to proteolyse and release E-cadherin, promot-
ing EMT in lens epithelial cells exposed to TGF-
(Dwivedi et al., 2006). It can also alter the ECM microen-
vironment to reveal cryptic proliferative sites in laminin
and collagen (Pirila et al., 2003) and generate “matrikines”
from processed ECM molecules (Tran et al., 2004). Al-
though we have not identified which of these possibilities
are most relevant here, we have shown that FGF-2 is
released from the lens capsule by MMP-2, and both are
required to protect lens epithelial cell from stress on the
lens capsule. These data also support the ECM-reservoir
hypothesis (Bergers et al., 2000; Mott and Werb, 2004) and
confirm that the lens capsule contains a store of accessible
FGF-2.
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